Kerry Group (LON:KYGA) Hits New 12-Month Low at $103.90

Kerry Group PLC (LON:KYGA) shares reached a new 52-week low during mid-day trading on Wednesday . The company traded as low as GBX 103.90 ($1.36) and last traded at GBX 104.20 ($1.36), with a volume of 47771 shares. The stock had previously closed at GBX 105.80 ($1.38).

Separately, Barclays reissued a “hold” rating and set a $52.00 target price on shares of Biohaven Pharmaceutical in a research report on Tuesday, March 19th.

The stock has a 50-day moving average of GBX 3,217.44. The firm has a market capitalization of $18.60 billion and a PE ratio of 3,447.82. The company has a current ratio of 1.38, a quick ratio of 0.84 and a debt-to-equity ratio of 53.02.

Kerry Group Company Profile (LON:KYGA)

Kerry Group plc, together with its subsidiaries, develops, manufactures, and delivers technology based taste and nutrition solutions for the food, beverage, and pharmaceutical industries in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company operates in two segments, Taste & Nutrition and Consumer Foods.

Read More: Trade War

Receive News & Ratings for Kerry Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kerry Group and related companies with MarketBeat.com's FREE daily email newsletter.